Search

23 Feb 2024: Search site. Office for Translational Research. poster_rcp_seminar_28nov20_-_vasculitis_and_lupus_resize2.jpg. 2024 University of Cambridge.

1 Jun 2024: basis.<br /> <strong>Dr David Jayne, Consultant in Nephrology and Vasculitis, Cambridge University Hospitals</strong><br /> David Jayne is an NHS consultant in nephrology and Director of the Vasculitis and Lupus ... biologic and other newer therapies in

23 Feb 2024: Clinical evaluation of newer immunotherapeutics in vasculitis, lupus and immune-mediated renal disease. ... Co-ordination of international clinical research vasculitis network (EUVAS) and multi-centre randomised controlled trials.

28 May 2024: Whilst lupus can be controlled through lifestyle changes and medical interventions, there is currently no cure. ... potentialbr / long-term value.”/p pImmune-mediated diseases, such as inflammatory bowel disease, vasculitis and Lupus are common,

23 Feb 2024: ANCA vasculitis and in kidney allograft rejection. ... Distinct pathogenic roles for resident and monocyte-derived macrophages in lupus nephritis.

31 May 2024: Prof David Jayne, Director of the Vasculitis and Lupus Service, Addenbrooke’s Hospital. ... Targeting approaches for respiratory infection . David Fairen-Jimenez. Department of Chemical Engineering and Biotechnology.

23 Feb 2024: Versus Arthritis Chair in Rheumatology. The McKinney lab uses a custom spotted oligo microarray platform to investigate gene expression signatures in autoimmune diseases, ANCA-associated systemic vasculitis and SLE. ... Professor of Clinical Autoimmunity.

23 Feb 2024: David Jayne. Evaluates immunotherapeutics in vasculitis, lupus and immune-mediated renal disease and co-ordinates the European Vasculitis Study Group (EUVAS) and multi-centre randomised controlled trials. ... Eoin McKinney. Investigates gene expression

23 Feb 2024: Professor of Clinical Autoimmunity, University of Cambridge. Director of the Vasculitis and Lupus Service, Addenbrooke’s Hospital. ... Biomarker development. Proetomic and microbiomic studies in vasculitis and lupus nephritis and collaboration with

23 Feb 2024: Search site. Cambridge Immunology Network. Dr Lisa Willcocks. The vasculitis and lupus clinic specialises in looking after patients with diseases caused by an overactive immune system (autoimmune diseases). ... The most common of these diseases, that

23 Feb 2024: The Experimental Medicine and Immunotherapeutics division has a strong record in clinical research. ... Professor David Jayne : Director of the Vasculitis and Lupus Service, Addenbrooke’s Hospital.

23 Feb 2024: and Smith, K.G.C. “Novel expression signatures identified by transcriptional analysis of separated leucocyte subsets in systemic lupus erythematosus and vasculitis.” Annals of the Rheumatic Diseases, 2010;69:1208-1213. ... and Salama, A.D.

23 Feb 2024: Wellcome Trust Senior Investigator. Honorary Consultant, Vasculitis and Lupus Clinic, Cambridge University Hospitals. ... FCEs provide interdisciplinary training programmes for students, fellows and continuing education physicians through FOCIS assisted

22 Feb 2023: long-term value.”. Immune-mediated diseases, such as inflammatory bowel disease, vasculitis and Lupus are common, chronic and incurable, and there is currently no way of knowing whether a patient is ... I’m delighted to welcome Paul to the team and

23 Feb 2024: Prof Andrew Grace, Department of Biochemistry, University of Cambridge and Royal Papworth Hospital NHS Foundation Trust. - ... Prof David Jayne, Director of the Vasculitis and Lupus Service, Cambridge University Hospitals NHS Foundation Trust. -

24 May 2013: David Jayne is an NHS consultant in nephrology and Director of the Vasculitis and Lupus unit at Addenbrooke’s Hospital, Cambridge. ... biologic and other newer therapies in vasculitis, systemic lupus erythematosus and Behcet’s disease.

uploads/2019/03/DavidJayne-HQ-819x1024.jpg 819w" sizes="(max-width: 240px) 100vw, 240px" //a/pnpClinical evaluation of newer immunotherapeutics in vasculitis, lupus and immune-mediated renal disease. ... Co-ordination of international clinical research

1 Jun 2024: basis.<br /> <strong>Dr David Jayne, Consultant in Nephrology and Vasculitis, Cambridge University Hospitals</strong><br /> David Jayne is an NHS consultant in nephrology and Director of the Vasculitis and Lupus ... biologic and other newer therapies in

28 May 2024: causing proteins within tumour cells and trigger pathways to eliminate these proteins, thereby halting further growth of the tumour. ... potentialbr / long-term value.”/p pImmune-mediated diseases, such as inflammatory bowel disease, vasculitis and

1 Jun 2024: basis.<br /> <strong>Dr David Jayne, Consultant in Nephrology and Vasculitis, Cambridge University Hospitals</strong><br /> David Jayne is an NHS consultant in nephrology and Director of the Vasculitis and Lupus ... biologic and other newer therapies in

23 Feb 2024: Search site. Cambridge Immunology Network. Dr Luis F. Quintana. Biomarker studies in ANCA-associated vasculitis, lupus and immune-mediated renal disease. ... We perform state-of-the-art proteomic analyses on plasma and urine samples of patients with

28 May 2024: PredictImmune and I’m honoured to have beenappointed to lead the company as it enters the commercialisation phase of its expansion. ... potentialbr / long-term value.”/p pImmune-mediated diseases, such as inflammatory bowel disease, vasculitis and

1 Jun 2024: basis.<br /> <strong>Dr David Jayne, Consultant in Nephrology and Vasculitis, Cambridge University Hospitals</strong><br /> David Jayne is an NHS consultant in nephrology and Director of the Vasculitis and Lupus ... biologic and other newer therapies in

23 Feb 2024: At the Department of Rheumatology, Lund University in Sweden, I am the PI of a comorbidity project addressing the frequencies and predictors of common morbidities in ANCA vasculitis and giant cell ... In June 2013, I joined a postdoctoral research

1 Jun 2024: basis.<br /> <strong>Dr David Jayne, Consultant in Nephrology and Vasculitis, Cambridge University Hospitals</strong><br /> David Jayne is an NHS consultant in nephrology and Director of the Vasculitis and Lupus ... biologic and other newer therapies in

28 May 2024: Whilst lupus can be controlled through lifestyle changes and medical interventions, there is currently no cure. ... potentialbr / long-term value.”/p pImmune-mediated diseases, such as inflammatory bowel disease, vasculitis and Lupus are common,

1 Jun 2024: basis.<br /> <strong>Dr David Jayne, Consultant in Nephrology and Vasculitis, Cambridge University Hospitals</strong><br /> David Jayne is an NHS consultant in nephrology and Director of the Vasculitis and Lupus ... biologic and other newer therapies in

23 Feb 2024: Senior Lecturer Transfusion Medicine. Arthritis Research UK rheumatology lecturer. Wellcome-Beit Prize and Intermediate Clinical Fellow. ... 01223 762127. Honorary Consultant, Vasculitis and Lupus Clinic, Cambridge University Hospitals.

1 Jun 2024: basis.<br /> <strong>Dr David Jayne, Consultant in Nephrology and Vasculitis, Cambridge University Hospitals</strong><br /> David Jayne is an NHS consultant in nephrology and Director of the Vasculitis and Lupus ... biologic and other newer therapies in

23 Feb 2024: Search site. Cambridge Immunology Network. Dr David Jayne. Clinical evaluation of newer immunotherapeutics in vasculitis, lupus and immune-mediated renal disease. ... Co-ordination of international clinical research vasculitis network (EUVAS) and

23 Feb 2024: Novel expression signatures identified by transcriptional analysis of separated leucocyte subsets in systemic lupus erythematosus and vasculitis. ... Microarray analysis of human leucocyte subsets: the advantages of positive selection and rapid

23 Feb 2024: This is a collaboration between clinicians, basic scientists and bioinformaticians that aims to apply expression profiling to the clinical management of autoimmune diseases such as systemic lupus erythematosus and small vessel ... vasculitis. We have

ANCA vasculitis and in kidney allograft rejection./linlibBladderu00a0/bu2013 We are investigatingu00a0how immune-epithelial-fibroblast cell circuits work during homeostasis and in bladder infection, how this differs between men and women ... strongDistinc

23 Feb 2024: Consultant Clinical Oncologist, Sunway Medical Centre, Malaysia. A recording of this webinar can be found Vasculitis and Lupus : November 2020. ... Overview of Vasculitis and Lupus. Dr Cheah Chee Ken. Consultant Physician and Rheumatologist, Sunway

23 Feb 2024: Work on almost any aspect of immunology has implications for inflammation and autoimmunity. ... Honorary Consultant, Vasculitis and Lupus Clinic, Cambridge University Hospitals. Investigator- Drug Discovery Biologist at GSK.

23 Feb 2024: Career Development Fellow. Translational Medicine and Therapeutics PhD Student. MRC Biomedical Informatics Fellow. ... Wellcome Trust Clinical Career Development Fellow. Honorary Consultant, Vasculitis and Lupus Clinic, Cambridge University Hospitals.

src="https://www.citiid.cam.ac.uk/wp-content/uploads/2019/03/vasculitis.jpg" width="100" //tdntd style="padding: 5px;"nh1David Jayne/h1npEvaluates immunotherapeutics in vasculitis, lupus and immune-mediated renal ... cam.ac.uk/wp-content/uploads/2019/03/h

23 Feb 2024: Work on almost any aspect of immunology has implications for inflammation and autoimmunity. ... Honorary Consultant, Vasculitis and Lupus Clinic, Cambridge University Hospitals. Investigator- Drug Discovery Biologist at GSK.

23 Feb 2024: Career Development Fellow. Translational Medicine and Therapeutics PhD Student. MRC Biomedical Informatics Fellow. ... Wellcome Trust Clinical Career Development Fellow. Honorary Consultant, Vasculitis and Lupus Clinic, Cambridge University Hospitals.

23 Feb 2024: collaborative study and meta-regression analysis</a>.<em><strong>The Lancet;</strong></em>2012. ... Afzali, P. Lavender, C. Hess and Claudia Kemper ( equal contribution and corresponding author).

23 Feb 2024: Work on almost any aspect of immunology has implications for inflammation and autoimmunity. ... Honorary Consultant, Vasculitis and Lupus Clinic, Cambridge University Hospitals. Investigator- Drug Discovery Biologist at GSK.

24 Nov 2022: Professor David Jayne Professor of Clinical Autoimmunity, University of Cambridge; Director of the Vasculitis and Lupus Service, Addenbrooke’s Hospital. ... and principle investigator on several other industry and academic vasculitis and lupus trials.

23 Feb 2024: and strongSmith, K.G.C./strong “Novel expression signatures identified by transcriptional analysis of separated leucocyte subsets in systemic lupus erythematosus and vasculitis.” strongAnnals of the Rheumatic Diseases,/strong ... and Salama, A.D.

23 Feb 2024: Career Development Fellow. Translational Medicine and Therapeutics PhD Student. MRC Biomedical Informatics Fellow. ... Wellcome Trust Clinical Career Development Fellow. Honorary Consultant, Vasculitis and Lupus Clinic, Cambridge University Hospitals.

23 Feb 2024: Work on almost any aspect of immunology has implications for inflammation and autoimmunity. ... Honorary Consultant, Vasculitis and Lupus Clinic, Cambridge University Hospitals. Investigator- Drug Discovery Biologist at GSK.

31 Jan 2022: patients and the public across the East of England, the UK and beyond. ... My tumour was triple negative and so I was eligible for the trial.